Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

NCT00871338 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Neisseria Meningitidis
Haemophilus Influenzae Type b

Interventions

BIOLOGICAL: GSK2197870A
BIOLOGICAL: Prevenar™
BIOLOGICAL: Menitorix™
BIOLOGICAL: Pediacel™
BIOLOGICAL: Menjugate™

Sponsor

GlaxoSmithKline